Kinepict gets FDA clearance for angiography software

By staff writers

March 10, 2020 -- Hungarian medical software developer Kinepict Health has garnered U.S. Food and Drug Administration (FDA) 510(k) clearance for its Kinepict Medical Imaging Tool (KMIT) software for angiography.

KMIT provides what the firm calls digital variance angiography (DVA), a technology that identifies contrast-induced changes in angiography images by using statistical methods to visualize blood vessels, according to the vendor. Using DVA instead of digital subtraction angiography yields a 2.5 to 10 times better contrast-to-noise ratio, 70% lower x-ray dose for the lower limb, and 50% lower contrast agent dose for imaging the carotid artery, Kinepict said.

The firm also pointed to image quality improvements from DVA when imaging blood vessels near metal implants and during prostate embolization.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking